Exploration of Multiple Synthetic Approaches toward Cyanogramide: Challenges, Mechanistic Insights, and Future Perspectives

Marine-derived alkaloids continue to gain significant attention because of their unique structures and promising medicinal properties. Among them, cyanogramides, which come from the marine actinobacterium Actinoalloteichus cyanogriseus, form a distinct group of alkaloids with a unique spirocyclic pyrrolo[1,2-c]imidazole structure. Cyanogramide appears as a yellow oil with the molecular formula C₂₄H₂₁N₃O₄. It has shown strong ability to reverse multidrug resistance (MDR) against adriamycin-resistant MCF-7, K562, and vincristine-resistant KB cancer cell lines, highlighting its potential as a promising anticancer candidate. Significant progress has been achieved toward the chemical synthesis of cyanogramides through enantioselective organocatalytic strategies. Thiourea-catalysed asymmetric spiro-annulation has enabled the efficient construction of the highly congested tetracyclic spirocyclic core with excellent stereocontrol, while electronic circular dichroism (ECD) studies have confirmed the absolute configuration of the natural product. The proposed synthetic pathway involves the coupling of an alkylidene indolinone with a thiocyanate-containing hydantoin precursor, followed by oxidative desulfurization, cyclisation, and selective methylation to furnish the characteristic spiro-pyrrolo [1,2-c]imidazole skeleton. This strategy provides a concise and biomimetic approach for assembling the complex molecular architecture of cyanogramide and serves as a valuable platform for analogue synthesis. Furthermore, the development of efficient and scalable synthetic methodologies for cyanogramide remains an important objective in synthetic organic chemistry. Continued efforts towards optimizing reaction conditions, improving overall yields, and expanding substrate scope are expected to facilitate the preparation of structurally diverse cyanogramide analogues.